Morawska, A.; Frankowski, R.; Grabarczyk, M.; Kosmalski, M.; Różycka-Kosmalska, M.
Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications. Life 2025, 15, 1713.
https://doi.org/10.3390/life15111713
AMA Style
Morawska A, Frankowski R, Grabarczyk M, Kosmalski M, Różycka-Kosmalska M.
Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications. Life. 2025; 15(11):1713.
https://doi.org/10.3390/life15111713
Chicago/Turabian Style
Morawska, Agata, Rafał Frankowski, Mikołaj Grabarczyk, Marcin Kosmalski, and Monika Różycka-Kosmalska.
2025. "Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications" Life 15, no. 11: 1713.
https://doi.org/10.3390/life15111713
APA Style
Morawska, A., Frankowski, R., Grabarczyk, M., Kosmalski, M., & Różycka-Kosmalska, M.
(2025). Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications. Life, 15(11), 1713.
https://doi.org/10.3390/life15111713
